'Ride on the ferrous wheel' - The cycle of iron in macrophages in health and disease

Immunobiology

Volumn 220, Issue 2, 2015, Pages 280-294

  Nairz, Manfred ^a   Schroll, Andrea ^a   Demetz, Egon ^a   Tancevski, Ivan ^a   Theurl, Igor ^a   Weiss, Günter ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Anemia of chronic disease; Anemia of inflammation; Infection; Iron; Macrophage; Nutritional immunity

Indexed keywords

IRON;

ADAPTATION; ATHEROSCLEROSIS; CELL FUNCTION; CELL INTERACTION; CELL POLARITY; CHRONIC INFLAMMATION; DISEASE ASSOCIATION; DISEASE COURSE; GENETIC DISORDER; HEMOLYTIC ANEMIA; HUMAN; IMMUNOBIOLOGY; IMMUNOCOMPETENT CELL; INFECTION; IRON BALANCE; IRON METABOLISM; IRON OVERLOAD; MACROPHAGE; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; ANIMAL; HOMEOSTASIS; IMMUNITY; IMMUNOLOGY; IMMUNOMODULATION; INFLAMMATION; METABOLISM; MICROBIOLOGY; MONONUCLEAR PHAGOCYTE; NEOPLASM;

ANEMIA, HEMOLYTIC; ANIMALS; HOMEOSTASIS; HUMANS; IMMUNITY; IMMUNOMODULATION; INFLAMMATION; IRON; IRON OVERLOAD; MACROPHAGES; MONONUCLEAR PHAGOCYTE SYSTEM; NEOPLASMS;

EID: 84922426001     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2014.09.010     Document Type: Review

References (243)

1. Agranoff D., Monahan I.M., Mangan J.A., Butcher P.D., Krishna S. Mycobacterium tuberculosis expresses a novel pH-dependent divalent cation transporter belonging to the Nramp family. J. Exp. Med. 1999, 190:717.
2. Alkhateeb A.A., Connor J.R. The significance of ferritin in cancer: anti-oxidation, inflammation and tumorigenesis. Biochim. Biophys. Acta 2013, 1836:245.
3. Anderson G.J., Frazer D.M., McKie A.T., Vulpe C.D., Smith A. Mechanisms of haem and non-haem iron absorption: lessons from inherited disorders of iron metabolism. Biometals 2005, 18:339.
4. Armand P., Kim H.T., Cutler C.S., Ho V.T., Koreth J., Alyea E.P., Soiffer R.J., Antin J.H. Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood 2007, 109:4586.
5. Armitage A.E., Eddowes L.A., Gileadi U., Cole S., Spottiswoode N., Selvakumar T.A., Ho L.P., Townsend A.R., Drakesmith H. Hepcidin regulation by innate immune and infectious stimuli. Blood 2011, 118:4129.
6. Ascherio A., Rimm E.B., Giovannucci E., Willett W.C., Stampfer M.J. Blood donations and risk of coronary heart disease in men. Circulation 2001, 103:52.
7. Bao G., Clifton M., Hoette T.M., Mori K., Deng S.X., Qiu A., Viltard M., Williams D., Paragas N., Leete T., Kulkarni R., Li X., Lee B., Kalandadze A., Ratner A.J., Pizarro J.C., Schmidt-Ott K.M., Landry D.W., Raymond K.N., Strong R.K., Barasch J. Iron traffics in circulation bound to a siderocalin (Ngal)-catechol complex. Nat. Chem. Biol. 2010, 6:602.
8. Barton C.H., Whitehead S.H., Blackwell J.M. Nramp transfection transfers Ity/Lsh/Bcg-related pleiotropic effects on macrophage activation: influence on oxidative burst and nitric oxide pathways. Mol. Med. 1995, 1:267.
9. Beaumont C., Delaby C. Recycling iron in normal and pathological states. Semin. Hematol. 2009, 46:328.
10. Bellmann-Weiler R., Schroll A., Engl S., Nairz M., Talasz H., Seifert M., Weiss G. Neutrophil gelatinase-associated lipocalin and interleukin-10 regulate intramacrophage Chlamydia pneumoniae replication by modulating intracellular iron homeostasis. Immunobiology 2013, 218:969.
11. Ben-Othman R., Flannery A.R., Miguel D.C., Ward D.M., Kaplan J., Andrews N.W. Leishmania-mediated inhibition of iron export promotes parasite replication in macrophages. PLOS Pathog. 2014, 10:e1003901.
12. Berger T., Togawa A., Duncan G.S., Elia A.J., You-Ten A., Wakeham A., Fong H.E., Cheung C.C., Mak T.W. Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:1834.
13. Bierry G., Jehl F., Boehm N., Robert P., Dietemann J.L., Kremer S. Macrophage imaging by USPIO-enhanced MR for the differentiation of infectious osteomyelitis and aseptic vertebral inflammation. Eur. Radiol. 2009, 19:1604.
14. Biswas S.K., Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 2010, 11:889.
15. Biswas S.K., Mantovani A. Orchestration of metabolism by macrophages. Cell Metab. 2012, 15:432.
16. Blackwell J.M., Barton C.H., White J.K., Roach T.I., Shaw M.A., Whitehead S.H., Mock B.A., Searle S., Williams H., Baker A.M. Genetic regulation of leishmanial and mycobacterial infections: the Lsh/Ity/Bcg gene story continues. Immunol. Lett. 1994, 43:99.
17. Blackwell J.M., Searle S., Mohamed H., White J.K. Divalent cation transport and susceptibility to infectious and autoimmune disease: continuation of the Ity/Lsh/Bcg/Nramp1/Slc11a1 gene story. Immunol. Lett. 2003, 85:197.
18. Bohlius J., Schmidlin K., Brillant C., Schwarzer G., Trelle S., Seidenfeld J., Zwahlen M., Clarke M., Weingart O., Kluge S., Piper M., Rades D., Steensma D.P., Djulbegovic B., Fey M.F., Ray-Coquard I., Machtay M., Moebus V., Thomas G., Untch M., Schumacher M., Egger M., Engert A. Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials. Lancet 2009, 373:1532.
19. Bories G., Colin S., Vanhoutte J., Derudas B., Copin C., Fanchon M., Daoudi M., Belloy L., Haulon S., Zawadzki C., Jude B., Staels B., Chinetti-Gbaguidi G. Liver X receptor activation stimulates iron export in human alternative macrophages. Circ. Res. 2013, 113:1196.
20. Bratosin D., Mazurier J., Tissier J.P., Estaquier J., Huart J.J., Ameisen J.C., Aminoff D., Montreuil J. Cellular and molecular mechanisms of senescent erythrocyte phagocytosis by macrophages. A review. Biochimie 1998, 80:173.
21. Breuer W., Shvartsman M., Cabantchik Z.I. Intracellular labile iron. Int. J. Biochem. Cell Biol. 2008, 40:350.
22. Cairo G., Recalcati S., Mantovani A., Locati M. Iron trafficking and metabolism in macrophages: contribution to the polarized phenotype. Trends Immunol. 2011, 32:241.
23. Cassat J.E., Skaar E.P. Iron in infection and immunity. Cell Host Microbe 2013, 13:509.
24. Chakraborty S., Kaur S., Guha S., Batra S.K. The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer. Biochim. Biophys. Acta 2012, 1826:129.
25. Chau J.Y., Tiffany C.M., Nimishakavi S., Lawrence J.A., Pakpour N., Mooney J.P., Lokken K.L., Caughey G.H., Tsolis R.M., Luckhart S. Malaria-associated l-arginine deficiency induces mast cell-associated disruption to intestinal barrier defenses against nontyphoidal Salmonella bacteremia. Infect. Immun. 2013, 81:3515.
26. Chen T.T., Li L., Chung D.H., Allen C.D., Torti S.V., Torti F.M., Cyster J.G., Chen C.Y., Brodsky F.M., Niemi E.C., Nakamura M.C., Seaman W.E., Daws M.R. TIM-2 is expressed on B cells and in liver and kidney and is a receptor for H-ferritin endocytosis. J. Exp. Med. 2005, 202:955.
27. Chen G., Fillebeen C., Wang J., Pantopoulos K. Overexpression of iron regulatory protein 1 suppresses growth of tumor xenografts. Carcinogenesis 2007, 28:785.
28. Cheng C., Noordeloos A.M., Jeney V., Soares M.P., Moll F., Pasterkamp G., Serruys P.W., Duckers H.J. Heme oxygenase 1 determines atherosclerotic lesion progression into a vulnerable plaque. Circulation 2009, 119:3017.
29. Chlosta S., Fishman D.S., Harrington L., Johnson E.E., Knutson M.D., Wessling-Resnick M., Cherayil B.J. The iron efflux protein ferroportin regulates the intracellular growth of Salmonella enterica. Infect. Immun. 2006, 74:3065.
30. Chow A., Huggins M., Ahmed J., Hashimoto D., Lucas D., Kunisaki Y., Pinho S., Leboeuf M., Noizat C., van Rooijen N., Tanaka M., Zhao Z.J., Bergman A., Merad M., Frenette P.S. CD169(+) macrophages provide a niche promoting erythropoiesis under homeostasis and stress. Nat. Med. 2013, 19:429.
31. Chung S.W., Liu X., Macias A.A., Baron R.M., Perrella M.A. Heme oxygenase-1-derived carbon monoxide enhances the host defense response to microbial sepsis in mice. J. Clin. Invest. 2008, 118:239.
32. Clemens D.L., Horwitz M.A. The Mycobacterium tuberculosis phagosome interacts with early endosomes and is accessible to exogenously administered transferrin. J. Exp. Med. 1996, 184:1349.
33. Corna G., Campana L., Pignatti E., Castiglioni A., Tagliafico E., Bosurgi L., Campanella A., Brunelli S., Manfredi A.A., Apostoli P., Silvestri L., Camaschella C., Rovere-Querini P. Polarization dictates iron handling by inflammatory and alternatively activated macrophages. Haematologica 2010, 95:1814.
34. Cornelis P., Dingemans J. Pseudomonas aeruginosa adapts its iron uptake strategies in function of the type of infections. Front. Cell Infect. Microbiol. 2013, 3:75.
35. Correnti C., Richardson V., Sia A.K., Bandaranayake A.D., Ruiz M., Suryo Rahmanto Y., Kovacevic Z., Clifton M.C., Holmes M.A., Kaiser B.K., Barasch J., Raymond K.N., Richardson D.R., Strong R.K. Siderocalin/Lcn2/NGAL/24p3 does not drive apoptosis through gentisic acid mediated iron withdrawal in hematopoietic cell lines. PLoS ONE 2012, 7:e43696.
36. Cozzi A., Levi S., Corsi B., Santambrogio P., Campanella A., Gerardi G., Arosio P. Role of iron and ferritin in TNFalpha-induced apoptosis in HeLa cells. FEBS Lett. 2003, 537:187.
37. Cromheeke K.M., Kockx M.M., De Meyer G.R., Bosmans J.M., Bult H., Beelaerts W.J., Vrints C.J., Herman A.G. Inducible nitric oxide synthase colocalizes with signs of lipid oxidation/peroxidation in human atherosclerotic plaques. Cardiovasc. Res. 1999, 43:744.
38. Crouch M.L., Castor M., Karlinsey J.E., Kalhorn T., Fang F.C. Biosynthesis and IroC-dependent export of the siderophore salmochelin are essential for virulence of Salmonella enterica serovar Typhimurium. Mol. Microbiol. 2008, 67:971.
39. Cunnington A.J., de Souza J.B., Walther M., Riley E.M. Malaria impairs resistance to Salmonella through heme- and heme oxygenase-dependent dysfunctional granulocyte mobilization. Nat. Med. 2011, 18:120.
40. Daldrup-Link H., Coussens L.M. MR imaging of tumor-associated macrophages. Oncoimmunology 2012, 1:507.
41. Das N.K., Biswas S., Solanki S., Mukhopadhyay C.K. Leishmania donovani depletes labile iron pool to exploit iron uptake capacity of macrophage for its intracellular growth. Cell Microbiol. 2009, 11:83.
42. De Domenico I., Zhang T.Y., Koening C.L., Branch R.W., London N., Lo E., Daynes R.A., Kushner J.P., Li D., Ward D.M., Kaplan J. Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice. J. Clin. Invest. 2010, 120:2395.
43. Deriu E., Liu J.Z., Pezeshki M., Edwards R.A., Ochoa R.J., Contreras H., Libby S.J., Fang F.C., Raffatellu M. Probiotic bacteria reduce salmonella typhimurium intestinal colonization by competing for iron. Cell Host Microbe 2013, 14:26.
44. Devireddy L.R., Gazin C., Zhu X., Green M.R. A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell 2005, 123:1293.
45. Devireddy L.R., Hart D.O., Goetz D.H., Green M.R. A mammalian siderophore synthesized by an enzyme with a bacterial homolog involved in enterobactin production. Cell 2010, 141:1006.
46. Dlaska M., Weiss G. Central role of transcription factor NF-IL6 for cytokine and iron-mediated regulation of murine inducible nitric oxide synthase expression. J. Immunol. 1999, 162:6171.
47. Drapier J.C., Hirling H., Wietzerbin J., Kaldy P., Kuhn L.C. Biosynthesis of nitric oxide activates iron regulatory factor in macrophages. EMBO J. 1993, 12:3643.
48. Eken C., Sadallah S., Martin P.J., Treves S., Schifferli J.A. Ectosomes of polymorphonuclear neutrophils activate multiple signaling pathways in macrophages. Immunobiology 2013, 218:382.
49. Eller K., Schroll A., Banas M., Kirsch A.H., Huber J.M., Nairz M., Skvortsov S., Weiss G., Rosenkranz A.R., Theurl I. Lipocalin-2 expressed in innate immune cells is an endogenous inhibitor of inflammation in murine nephrotoxic serum nephritis. PLOS ONE 2013, 8:e67693.
50. Epiphanio S., Mikolajczak S.A., Goncalves L.A., Pamplona A., Portugal S., Albuquerque S., Goldberg M., Rebelo S., Anderson D.G., Akinc A., Vornlocher H.P., Kappe S.H., Soares M.P., Mota M.M. Heme oxygenase-1 is an anti-inflammatory host factor that promotes murine plasmodium liver infection. Cell Host Microbe 2008, 3:331.
51. Evstatiev R., Gasche C. Iron sensing and signalling. Gut 2012, 61:933.
52. Fan Y., Wang J., Wei L., He B., Wang C., Wang B. Iron deficiency activates pro-inflammatory signaling in macrophages and foam cells via the p38 MAPK-NF-kappaB pathway. Int. J. Cardiol. 2011, 152:49.
53. Fargion S., Fracanzani A.L., Brando B., Arosio P., Levi S., Fiorelli G. Specific binding sites for H-ferritin on human lymphocytes: modulation during cellular proliferation and potential implication in cell growth control. Blood 1991, 78:1056.
54. Finn A.V., Nakano M., Polavarapu R., Karmali V., Saeed O., Zhao X., Yazdani S., Otsuka F., Davis T., Habib A., Narula J., Kolodgie F.D., Virmani R. Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques. J. Am. Coll. Cardiol. 2012, 59:166.
55. Flo T.H., Smith K.D., Sato S., Rodriguez D.J., Holmes M.A., Strong R.K., Akira S., Aderem A. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 2004, 432:917.
56. Forbes J.R., Gros P. Divalent-metal transport by NRAMP proteins at the interface of host-pathogen interactions. Trends Microbiol. 2001, 9:397.
57. Frank K.M., Schneewind O., Shieh W.J. Investigation of a researcher's death due to septicemic plague. N. Engl. J. Med. 2011, 364:2563.
58. Fritsche G., Dlaska M., Barton H., Theurl I., Garimorth K., Weiss G. Nramp1 functionality increases inducible nitric oxide synthase transcription via stimulation of IFN regulatory factor 1 expression. J. Immunol. 2003, 171:1994.
59. Fritsche G., Nairz M., Theurl I., Mair S., Bellmann-Weiler R., Barton H.C., Weiss G. Modulation of macrophage iron transport by Nramp1 (Slc11a1). Immunobiology 2007, 212:751.
60. Fritsche G., Nairz M., Werner E.R., Barton H.C., Weiss G. Nramp1-functionality increases iNOS expression via repression of IL-10 formation. Eur. J. Immunol. 2008, 38:3060.
61. Fritsche G., Nairz M., Libby S.J., Fang F.C., Weiss G. Slc11a1 (Nramp1) impairs growth of Salmonella enterica serovar typhimurium in macrophages via stimulation of lipocalin-2 expression. J. Leukoc. Biol. 2012, 92:353.
62. Gaenzer H., Marschang P., Sturm W., Neumayr G., Vogel W., Patsch J., Weiss G. Association between increased iron stores and impaired endothelial function in patients with hereditary hemochromatosis. J. Am. Coll. Cardiol. 2002, 40:2189.
63. Galdiero M.R., Bonavita E., Barajon I., Garlanda C., Mantovani A., Jaillon S. Tumor associated macrophages and neutrophils in cancer. Immunobiology 2013, 218:1402.
64. Ganz T. Macrophages and systemic iron homeostasis. J. Innate Immun. 2012, 4:446.
65. Gardenghi S., Marongiu M.F., Ramos P., Guy E., Breda L., Chadburn A., Liu Y., Amariglio N., Rechavi G., Rachmilewitz E.A., Breuer W., Cabantchik Z.I., Wrighting D.M., Andrews N.C., de Sousa M., Giardina P.J., Grady R.W., Rivella S. Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin. Blood 2007, 109:5027.
66. Gardenghi S., Ramos P., Marongiu M.F., Melchiori L., Breda L., Guy E., Muirhead K., Rao N., Roy C.N., Andrews N.C., Nemeth E., Follenzi A., An X., Mohandas N., Ginzburg Y., Rachmilewitz E.A., Giardina P.J., Grady R.W., Rivella S. Hepcidin as a therapeutic tool to limit iron overload and improve anemia in beta-thalassemic mice. J. Clin. Invest. 2010, 120:4466.
67. Goldberg S.L., Chen E., Corral M., Guo A., Mody-Patel N., Pecora A.L., Laouri M. Incidence and clinical complications of myelodysplastic syndromes among United States Medicare beneficiaries. J. Clin. Oncol. 2010, 28:2847.
68. Gomes-Pereira S., Rodrigues P.N., Appelberg R., Gomes M.S. Increased susceptibility to Mycobacterium avium in hemochromatosis protein HFE-deficient mice. Infect. Immun. 2008, 76:4713.
69. Gozzelino R., Jeney V., Soares M.P. Mechanisms of cell protection by heme oxygenase-1. Annu. Rev. Pharmacol. Toxicol. 2010, 50:323.
70. Gunshin H., Mackenzie B., Berger U.V., Gunshin Y., Romero M.F., Boron W.F., Nussberger S., Gollan J.L., Hediger M.A. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997, 388:482.
71. Halaas O., Steigedal M., Haug M., Awuh J.A., Ryan L., Brech A., Sato S., Husebye H., Cangelosi G.A., Akira S., Strong R.K., Espevik T., Flo T.H. Intracellular Mycobacterium avium intersect transferrin in the Rab11(+) recycling endocytic pathway and avoid lipocalin 2 trafficking to the lysosomal pathway. J. Infect. Dis. 2010, 201:783.
72. Haldar M., Kohyama M., So A.Y., Kc W., Wu X., Briseno C.G., Satpathy A.T., Kretzer N.M., Arase H., Rajasekaran N.S., Wang L., Egawa T., Igarashi K., Baltimore D., Murphy T.L., Murphy K.M. Heme-mediated SPI-C induction promotes monocyte differentiation into iron-recycling macrophages. Cell 2014, 156:1223.
73. Hamilton T.A., Wada H.G., Sussman H.H. Identification of transferrin receptors on the surface of human cultured cells. Proc. Natl. Acad. Sci. U.S.A. 1979, 76:6406.
74. He F., Ma L., Wang H., Shen Z., Li M. Glucocorticoid causes iron accumulation in liver by up-regulating expression of iron regulatory protein 1 gene through GR and STAT5. Cell Biochem. Biophys. 2011, 61:65.
75. Hedges J.F., Kimmel E., Snyder D.T., Jerome M., Jutila M.A. Solute carrier 11A1 is expressed by innate lymphocytes and augments their activation. J. Immunol. 2013, 190:4263.
76. Hentze M.W., Muckenthaler M.U., Galy B., Camaschella C. Two to tango: regulation of Mammalian iron metabolism. Cell 2010, 142:24.
77. Hogemann-Savellano D., Bos E., Blondet C., Sato F., Abe T., Josephson L., Weissleder R., Gaudet J., Sgroi D., Peters P.J., Basilion J.P. The transferrin receptor: a potential molecular imaging marker for human cancer. Neoplasia 2003, 5:495.
78. Huntoon K.M., Wang Y., Eppolito C.A., Barbour K.W., Berger F.G., Shrikant P.A., Baumann H. The acute phase protein haptoglobin regulates host immunity. J. Leukoc. Biol. 2008, 84:170.
79. Hvidberg V., Maniecki M.B., Jacobsen C., Hojrup P., Moller H.J., Moestrup S.K. Identification of the receptor scavenging hemopexin-heme complexes. Blood 2005, 106:2572.
80. Ibrahim A.S., Edwards J.E., Fu Y., Spellberg B. Deferiprone iron chelation as a novel therapy for experimental mucormycosis. J. Antimicrob. Chemother. 2006, 58:1070.
81. Ibrahim A.S., Gebermariam T., Fu Y., Lin L., Husseiny M.I., French S.W., Schwartz J., Skory C.D., Edwards J.E., Spellberg B.J. The iron chelator deferasirox protects mice from mucormycosis through iron starvation. J. Clin. Invest. 2007, 117:2649.
82. Imlay J.A., Chin S.M., Linn S. Toxic DNA damage by hydrogen peroxide through the Fenton reaction in vivo and in vitro. Science 1988, 240:640.
83. Jezequel P., Campion L., Spyratos F., Loussouarn D., Campone M., Guerin-Charbonnel C., Joalland M.P., Andre J., Descotes F., Grenot C., Roy P., Carlioz A., Martin P.M., Chassevent A., Jourdan M.L., Ricolleau G. Validation of tumor-associated macrophage ferritin light chain as a prognostic biomarker in node-negative breast cancer tumors: a multicentric 2004 national PHRC study. Int. J. Cancer 2012, 131:426.
84. Kahnert A., Seiler P., Stein M., Bandermann S., Hahnke K., Mollenkopf H., Kaufmann S.H. Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis. Eur. J. Immunol. 2006, 36:631.
85. Karlinsey J.E., Maguire M.E., Becker L.A., Crouch M.L., Fang F.C. The phage shock protein PspA facilitates divalent metal transport and is required for virulence of Salmonella enterica sv. Typhimurium. Mol. Microbiol. 2010, 78:669.
86. Kautz L., Gabayan V., Wang X., Wu J., Onwuzurike J., Jung G., Qiao B., Lusis A.J., Ganz T., Nemeth E. Testing the iron hypothesis in a mouse model of atherosclerosis. Cell Rep. 2013, 5:1436.
87. Keel S.B., Doty R.T., Yang Z., Quigley J.G., Chen J., Knoblaugh S., Kingsley P.D., De Domenico I., Vaughn M.B., Kaplan J., Palis J., Abkowitz J.L. A heme export protein is required for red blood cell differentiation and iron homeostasis. Science 2008, 319:825.
88. Kehres D.G., Zaharik M.L., Finlay B.B., Maguire M.E. The NRAMP proteins of Salmonella typhimurium and Escherichia coli are selective manganese transporters involved in the response to reactive oxygen. Mol. Microbiol. 2000, 36:1085.
89. Kehres D.G., Janakiraman A., Slauch J.M., Maguire M.E. Regulation of Salmonella enterica serovar Typhimurium mntH transcription by H(2)O(2), Fe(2+), and Mn(2+). J. Bacteriol. 2002, 184:3151.
90. Kiechl S., Willeit J. Ongoing controversies surrounding the vascular benefits of blood donation. Circulation 2001, 104:E99.
91. Kiechl S., Aichner F., Gerstenbrand F., Egger G., Mair A., Rungger G., Spogler F., Jarosch E., Oberhollenzer F., Willeit J. Body iron stores and presence of carotid atherosclerosis. Results from the Bruneck Study. Arterioscler. Thromb. 1994, 14:1625.
92. Kiechl S., Willeit J., Egger G., Poewe W., Oberhollenzer F. Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Circulation 1997, 96:3300.
93. Kim D.K., Jeong J.H., Lee J.M., Kim K.S., Park S.H., Kim Y.D., Koh M., Shin M., Jung Y.S., Kim H.S., Lee T.H., Oh B.C., Kim J.I., Park H.T., Jeong W.I., Lee C.H., Park S.B., Min J.J., Jung S.I., Choi S.Y., Choy H.E., Choi H.S. Inverse agonist of estrogen-related receptor gamma controls Salmonella typhimurium infection by modulating host iron homeostasis. Nat. Med. 2014, 20:419.
94. Kitamura H., Morikawa H., Kamon H., Iguchi M., Hojyo S., Fukada T., Yamashita S., Kaisho T., Akira S., Murakami M., Hirano T. Toll-like receptor-mediated regulation of zinc homeostasis influences dendritic cell function. Nat. Immunol. 2006, 7:971.
95. Koening C.L., Miller J.C., Nelson J.M., Ward D.M., Kushner J.P., Bockenstedt L.K., Weis J.J., Kaplan J., De Domenico I. Toll-like receptors mediate induction of hepcidin in mice infected with Borrelia burgdorferi. Blood 2009, 114:1913.
96. Kraml P.J., Klein R.L., Huang Y., Nareika A., Lopes-Virella M.F. Iron loading increases cholesterol accumulation and macrophage scavenger receptor I expression in THP-1 mononuclear phagocytes. Metabolism. 2005, 54:453.
97. Kristiansen M., Graversen J.H., Jacobsen C., Sonne O., Hoffman H.J., Law S.K., Moestrup S.K. Identification of the haemoglobin scavenger receptor. Nature 2001, 409:198.
98. Kuvibidila S.R., Porretta C. Iron deficiency and in vitro iron chelation reduce the expression of cluster of differentiation molecule (CD)28 but not CD3 receptors on murine thymocytes and spleen cells. Br. J. Nutr. 2003, 90:179.
99. Larsen R., Gozzelino R., Jeney V., Tokaji L., Bozza F.A., Japiassu A.M., Bonaparte D., Cavalcante M.M., Chora A., Ferreira A., Marguti I., Cardoso S., Sepulveda N., Smith A., Soares M.P. A central role for free heme in the pathogenesis of severe sepsis. Sci. Transl. Med. 2010, 2:51ra71.
100. Larson J.A., Howie H.L., So M. Neisseria meningitidis accelerates ferritin degradation in host epithelial cells to yield an essential iron source. Mol. Microbiol. 2004, 53:807.
101. Laskar A., Eilertsen J., Li W., Yuan X.M. SPION primes THP1 derived M2 macrophages towards M1-like macrophages. Biochem. Biophys. Res. Commun. 2013, 441:737.
102. Le Blanc S., Garrick M.D., Arredondo M. Heme carrier protein 1 transports heme and is involved in heme-Fe metabolism. Am. J. Physiol. Cell Physiol. 2012, 302:C1780.
103. Leal S.M., Roy S., Vareechon C., Carrion S., Clark H., Lopez-Berges M.S., Di Pietro A., Schrettl M., Beckmann N., Redl B., Haas H., Pearlman E. Targeting iron acquisition blocks infection with the fungal pathogens Aspergillus fumigatus and Fusarium oxysporum. PLOS Pathog. 2013, 9:e1003436.
104. Lee T.S., Chau L.Y. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat. Med. 2002, 8:240.
105. Lee T.S., Shiao M.S., Pan C.C., Chau L.Y. Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice. Circulation 1999, 99:1222.
106. Lee P., Peng H., Gelbart T., Wang L., Beutler E. Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:1906.
107. Lee S.J., Park S.Y., Jung M.Y., Bae S.M., Kim I.S. Mechanism for phosphatidylserine-dependent erythrophagocytosis in mouse liver. Blood 2011, 117:5215.
108. Leung S., Holbrook A., King B., Lu H.T., Evans V., Miyamoto N., Mallari C., Harvey S., Davey D., Ho E., Li W.W., Parkinson J., Horuk R., Jaroch S., Berger M., Skuballa W., West C., Pulk R., Phillips G., Bryant J., Subramanyam B., Schaefer C., Salamon H., Lyons E., Schilling D., Seidel H., Kraetzschmar J., Snider M., Perez D. Differential inhibition of inducible T cell cytokine secretion by potent iron chelators. J. Biomol. Screen 2005, 10:157.
109. Li W., Xu L.H., Forssell C., Sullivan J.L., Yuan X.M. Overexpression of transferrin receptor and ferritin related to clinical symptoms and destabilization of human carotid plaques. Exp. Biol. Med. (Maywood) 2008, 233:818.
110. Li J.Y., Paragas N., Ned R.M., Qiu A., Viltard M., Leete T., Drexler I.R., Chen X., Sanna-Cherchi S., Mohammed F., Williams D., Lin C.S., Schmidt-Ott K.M., Andrews N.C., Barasch J. Scara5 is a ferritin receptor mediating non-transferrin iron delivery. Dev. Cell 2009, 16:35.
111. Li H., Rybicki A.C., Suzuka S.M., von Bonsdorff L., Breuer W., Hall C.B., Cabantchik Z.I., Bouhassira E.E., Fabry M.E., Ginzburg Y.Z. Transferrin therapy ameliorates disease in beta-thalassemic mice. Nat. Med. 2010, 16:177.
112. Li X., Yang Y., Zhou F., Zhang Y., Lu H., Jin Q., Gao L. SLC11A1 (NRAMP1) polymorphisms and tuberculosis susceptibility: updated systematic review and meta-analysis. PLoS ONE 2011, 6:e15831.
113. Li J.J., Meng X., Si H.P., Zhang C., Lv H.X., Zhao Y.X., Yang J.M., Dong M., Zhang K., Liu S.X., Zhao X.Q., Gao F., Liu X.L., Cui T.X., Zhang Y. Hepcidin destabilizes atherosclerotic plaque via overactivating macrophages after erythrophagocytosis. Arterioscler. Thromb. Vasc. Biol. 2012, 32:1158.
114. Lin L., Pantapalangkoor P., Tan B., Bruhn K.W., Ho T., Nielsen T., Skaar E.P., Zhang Y., Bai R., Wang A., Doherty T.M., Spellberg B. Transferrin iron starvation therapy for lethal bacterial and fungal infections. J. Infect. Dis. 2014, 210:254.
115. Liu Z., Reba S., Chen W.D., Porwal S.K., Boom W.H., Petersen R.B., Rojas R., Viswanathan R., Devireddy L.R. Regulation of mammalian siderophore 2,5-DHBA in the innate immune response to infection. J. Exp. Med. 2014, 211:1197.
116. Lokken K.L., Mooney J.P., Butler B.P., Xavier M.N., Chau J.Y., Schaltenberg N., Begum R.H., Muller W., Luckhart S., Tsolis R.M. Malaria parasite infection compromises control of concurrent systemic non-typhoidal Salmonella infection via IL-10-mediated alteration of myeloid cell function. PLOS Pathog. 2014, 10:e1004049.
117. Ludwiczek S., Aigner E., Theurl I., Weiss G. Cytokine-mediated regulation of iron transport in human monocytic cells. Blood 2003, 101:4148.
118. Ma Q. Role of nrf2 in oxidative stress and toxicity. Annu. Rev. Pharmacol. Toxicol. 2013, 53:401.
119. Macedo M.F., de Sousa M., Ned R.M., Mascarenhas C., Andrews N.C., Correia-Neves M. Transferrin is required for early T-cell differentiation. Immunology 2004, 112:543.
120. Marro S., Chiabrando D., Messana E., Stolte J., Turco E., Tolosano E., Muckenthaler M.U. Heme controls ferroportin1 (FPN1) transcription involving Bach1, Nrf2 and a MARE/ARE sequence motif at position-7007 of the FPN1 promoter. Haematologica 2010, 95:1261.
121. Mayr R., Janecke A.R., Schranz M., Griffiths W.J., Vogel W., Pietrangelo A., Zoller H. Ferroportin disease: a systematic meta-analysis of clinical and molecular findings. J. Hepatol. 2010, 53:941.
122. Melillo G., Taylor L.S., Brooks A., Musso T., Cox G.W., Varesio L. Functional requirement of the hypoxia-responsive element in the activation of the inducible nitric oxide synthase promoter by the iron chelator desferrioxamine. J. Biol. Chem. 1997, 272:12236.
123. Michalska M., Machtoub L., Manthey H.D., Bauer E., Herold V., Krohne G., Lykowsky G., Hildenbrand M., Kampf T., Jakob P., Zernecke A., Bauer W.R. Visualization of vascular inflammation in the atherosclerotic mouse by ultrasmall superparamagnetic iron oxide vascular cell adhesion molecule-1-specific nanoparticles. Arterioscler. Thromb. Vasc. Biol. 2012, 32:2350.
124. Miller M., Hutchins G.M. Hemochromatosis, multiorgan hemosiderosis, and coronary artery disease. JAMA 1994, 272:231.
125. Minqin R., Rajendran R., Pan N., Tan B.K., Ong W.Y., Watt F., Halliwell B. The iron chelator desferrioxamine inhibits atherosclerotic lesion development and decreases lesion iron concentrations in the cholesterol-fed rabbit. Free Radic. Biol. Med. 2005, 38:1206.
126. Mitchell K.M., Dotson A.L., Cool K.M., Chakrabarty A., Benedict S.H., LeVine S.M. Deferiprone, an orally deliverable iron chelator, ameliorates experimental autoimmune encephalomyelitis. Mult. Scler. 2007, 13:1118.
127. Moore M., Folsom A.R., Barnes R.W., Eckfeldt J.H. No association between serum ferritin and asymptomatic carotid atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Am. J. Epidemiol. 1995, 141:719.
128. Morishige K., Kacher D.F., Libby P., Josephson L., Ganz P., Weissleder R., Aikawa M. High-resolution magnetic resonance imaging enhanced with superparamagnetic nanoparticles measures macrophage burden in atherosclerosis. Circulation 2010, 122:1707.
129. Moura E., Noordermeer M.A., Verhoeven N., Verheul A.F., Marx J.J. Iron release from human monocytes after erythrophagocytosis in vitro: an investigation in normal subjects and hereditary hemochromatosis patients. Blood 1998, 92:2511.
130. Moura D.F., de Mattos K.A., Amadeu T.P., Andrade P.R., Sales J.S., Schmitz V., Nery J.A., Pinheiro R.O., Sarno E.N. CD163 favors Mycobacterium leprae survival and persistence by promoting anti-inflammatory pathways in lepromatous macrophages. Eur. J. Immunol. 2012, 42:2925.
131. Nagy E., Eaton J.W., Jeney V., Soares M.P., Varga Z., Galajda Z., Szentmiklosi J., Mehes G., Csonka T., Smith A., Vercellotti G.M., Balla G., Balla J. Red cells, hemoglobin, heme, iron, and atherogenesis. Arterioscler. Thromb. Vasc. Biol. 2010, 30:1347.
132. Nairz M., Theurl I., Ludwiczek S., Theurl M., Mair S.M., Fritsche G., Weiss G. The co-ordinated regulation of iron homeostasis in murine macrophages limits the availability of iron for intracellular Salmonella typhimurium. Cell Microbiol. 2007, 9:2126.
133. Nairz M., Fritsche G., Brunner P., Talasz H., Hantke K., Weiss G. Interferon-gamma limits the availability of iron for intramacrophage Salmonella typhimurium. Eur. J. Immunol. 2008, 38:1923.
134. Nairz M., Theurl I., Schroll A., Theurl M., Fritsche G., Lindner E., Seifert M., Crouch M.L., Hantke K., Akira S., Fang F.C., Weiss G. Absence of functional Hfe protects mice from invasive Salmonella enterica serovar Typhimurium infection via induction of lipocalin-2. Blood 2009, 114:3642.
135. Nairz M., Schroll A., Sonnweber T., Weiss G. The struggle for iron - a metal at the host-pathogen interface. Cell Microbiol. 2010, 12:1691.
136. Nairz M., Schleicher U., Schroll A., Sonnweber T., Theurl I., Ludwiczek S., Talasz H., Brandacher G., Moser P.L., Muckenthaler M.U., Fang F.C., Bogdan C., Weiss G. Nitric oxide-mediated regulation of ferroportin-1 controls macrophage iron homeostasis and immune function in Salmonella infection. J. Exp. Med. 2013, 210:855.
137. Nemeth E., Ganz T. Regulation of iron metabolism by hepcidin. Annu. Rev. Nutr. 2006, 26:323.
138. Nemeth E., Valore E.V., Territo M., Schiller G., Lichtenstein A., Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 2003, 101:2461.
139. Nemeth E., Tuttle M.S., Powelson J., Vaughn M.B., Donovan A., Ward D.M., Ganz T., Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004, 306:2090.
140. Nix R.N., Altschuler S.E., Henson P.M., Detweiler C.S. Hemophagocytic macrophages harbor Salmonella enterica during persistent infection. PLoS Pathog. 2007, 3:e193.
141. Oexle H., Kaser A., Most J., Bellmann-Weiler R., Werner E.R., Werner-Felmayer G., Weiss G. Pathways for the regulation of interferon-gamma-inducible genes by iron in human monocytic cells. J. Leukoc. Biol. 2003, 74:287.
142. Olakanmi O., Schlesinger L.S., Ahmed A., Britigan B.E. Intraphagosomal Mycobacterium tuberculosis acquires iron from both extracellular transferrin and intracellular iron pools. Impact of interferon-gamma and hemochromatosis. J. Biol. Chem. 2002, 277:49727.
143. Ong S.T., Ho J.Z., Ho B., Ding J.L. Iron-withholding strategy in innate immunity. Immunobiology 2006, 211:295.
144. Otogawa K., Kinoshita K., Fujii H., Sakabe M., Shiga R., Nakatani K., Ikeda K., Nakajima Y., Ikura Y., Ueda M., Arakawa T., Hato F., Kawada N. Erythrophagocytosis by liver macrophages (Kupffer cells) promotes oxidative stress, inflammation, and fibrosis in a rabbit model of steatohepatitis: implications for the pathogenesis of human nonalcoholic steatohepatitis. Am. J. Pathol. 2007, 170:967.
145. Pagani A., Nai A., Corna G., Bosurgi L., Rovere-Querini P., Camaschella C., Silvestri L. Low hepcidin accounts for the proinflammatory status associated with iron deficiency. Blood 2011, 118:736.
146. Paiva C.N., Feijo D.F., Dutra F.F., Carneiro V.C., Freitas G.B., Alves L.S., Mesquita J., Fortes G.B., Figueiredo R.T., Souza H.S., Fantappie M.R., Lannes-Vieira J., Bozza M.T. Oxidative stress fuels Trypanosoma cruzi infection in mice. J. Clin. Invest. 2012, 122:2531.
147. Pantopoulos K., Porwal S.K., Tartakoff A., Devireddy L. Mechanisms of mammalian iron homeostasis. Biochemistry 2012, 51:5705.
148. Paradkar P.N., De Domenico I., Durchfort N., Zohn I., Kaplan J., Ward D.M. Iron depletion limits intracellular bacterial growth in macrophages. Blood 2008, 112:866.
149. Paragas N., Qiu A., Hollmen M., Nickolas T.L., Devarajan P., Barasch J. NGAL-Siderocalin in kidney disease. Biochim. Biophys. Acta 2012, 1823:1451.
150. Park S.Y., Jung M.Y., Lee S.J., Kang K.B., Gratchev A., Riabov V., Kzhyshkowska J., Kim I.S. Stabilin-1 mediates phosphatidylserine-dependent clearance of cell corpses in alternatively activated macrophages. J. Cell Sci. 2009, 122:3365.
151. Peyssonnaux C., Zinkernagel A.S., Datta V., Lauth X., Johnson R.S., Nizet V. TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens. Blood 2006, 107:3727.
152. Pham C.G., Bubici C., Zazzeroni F., Papa S., Jones J., Alvarez K., Jayawardena S., De Smaele E., Cong R., Beaumont C., Torti F.M., Torti S.V., Franzoso G. Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell 2004, 119:529.
153. Philippidis P., Mason J.C., Evans B.J., Nadra I., Taylor K.M., Haskard D.O., Landis R.C. Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery. Circ. Res. 2004, 94:119.
154. Pietrangelo A. Hereditary hemochromatosis - a new look at an old disease. N. Engl. J. Med. 2004, 350:2383.
155. Pietrangelo A. Hemochromatosis: an endocrine liver disease. Hepatology 2007, 46:1291.
156. Pinnix Z.K., Miller L.D., Wang W., D'Agostino R., Kute T., Willingham M.C., Hatcher H., Tesfay L., Sui G., Di X., Torti S.V., Torti F.M. Ferroportin and iron regulation in breast cancer progression and prognosis. Sci. Transl. Med. 2010, 2:43ra56.
157. Pinto J.P., Arezes J., Dias V., Oliveira S., Vieira I., Costa M., Vos M., Carlsson A., Rikers Y., Rangel M., Porto G. Physiological implications of NTBI uptake by T lymphocytes. Front. Pharmacol. 2014, 5:24.
158. Pirart J., Barbier P. Protective effects of hemochromatosis against senile and diabetic angiopathies. Diabetologia 1971, 7:227.
159. Platzbecker U., Bornhauser M., Germing U., Stumpf J., Scott B.L., Kroger N., Schwerdtfeger R., Bohm A., Kobbe G., Theuser C., Rabitsch W., Valent P., Sorror M.L., Ehninger G., Deeg H.J. Red blood cell transfusion dependence and outcome after allogeneic peripheral blood stem cell transplantation in patients with de novo myelodysplastic syndrome (MDS). Biol. Blood Marrow Transpl. 2008, 14:1217.
160. Portugal S., Carret C., Recker M., Armitage A.E., Goncalves L.A., Epiphanio S., Sullivan D., Roy C., Newbold C.I., Drakesmith H., Mota M.M. Host-mediated regulation of superinfection in malaria. Nat. Med. 2011, 17:732.
161. Pullarkat V. Objectives of iron chelation therapy in myelodysplastic syndromes: more than meets the eye?. Blood 2009, 114:5251.
162. Raffatellu M., George M.D., Akiyama Y., Hornsby M.J., Nuccio S.P., Paixao T.A., Butler B.P., Chu H., Santos R.L., Berger T., Mak T.W., Tsolis R.M., Bevins C.L., Solnick J.V., Dandekar S., Baumler A.J. Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. Cell Host Microbe 2009, 5:476.
163. Recalcati S., Locati M., Marini A., Santambrogio P., Zaninotto F., De Pizzol M., Zammataro L., Girelli D., Cairo G. Differential regulation of iron homeostasis during human macrophage polarized activation. Eur. J. Immunol. 2010, 40:824.
164. Regis G., Bosticardo M., Conti L., De Angelis S., Boselli D., Tomaino B., Bernabei P., Giovarelli M., Novelli F. Iron regulates T-lymphocyte sensitivity to the IFN-gamma/STAT1 signaling pathway in vitro and in vivo. Blood 2005, 105:3214.
165. Robbins C.S., Hilgendorf I., Weber G.F., Theurl I., Iwamoto Y., Figueiredo J.L., Gorbatov R., Sukhova G.K., Gerhardt L.M., Smyth D., Zavitz C.C., Shikatani E.A., Parsons M., van Rooijen N., Lin H.Y., Husain M., Libby P., Nahrendorf M., Weissleder R., Swirski F.K. Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat. Med. 2013, 19:1166.
166. Rodrigues P.N., Gomes S.S., Neves J.V., Gomes-Pereira S., Correia-Neves M., Nunes-Alves C., Stolte J., Sanchez M., Appelberg R., Muckenthaler M.U., Gomes M.S. Mycobacteria-induced anaemia revisited: a molecular approach reveals the involvement of NRAMP1 and lipocalin-2, but not of hepcidin. Immunobiology 2011, 216:1127.
167. Rogers J.T. Ferritin translation by interleukin-1and interleukin-6: the role of sequences upstream of the start codons of the heavy and light subunit genes. Blood 1996, 87:2525.
168. Rolla S., Ingoglia G., Bardina V., Silengo L., Altruda F., Novelli F., Tolosano E. Acute-phase protein hemopexin is a negative regulator of Th17 response and experimental autoimmune encephalomyelitis development. J. Immunol. 2013, 191:5451.
169. Roux C.M., Butler B.P., Chau J.Y., Paixao T.A., Cheung K.W., Santos R.L., Luckhart S., Tsolis R.M. Both hemolytic anemia and malaria parasite-specific factors increase susceptibility to Nontyphoidal Salmonella enterica serovar typhimurium infection in mice. Infect. Immun. 2010, 78:1520.
170. Ryter S.W., Choi A.M. Heme oxygenase-1/carbon monoxide: novel therapeutic strategies in critical care medicine. Curr. Drug Targets 2010, 11:1485.
171. Saeed O., Otsuka F., Polavarapu R., Karmali V., Weiss D., Davis T., Rostad B., Pachura K., Adams L., Elliott J., Taylor W.R., Narula J., Kolodgie F., Virmani R., Hong C.C., Finn A.V. Pharmacological suppression of hepcidin increases macrophage cholesterol efflux and reduces foam cell formation and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2012, 32:299.
172. Sazawal S., Black R.E., Ramsan M., Chwaya H.M., Stoltzfus R.J., Dutta A., Dhingra U., Kabole I., Deb S., Othman M.K., Kabole F.M. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. Lancet 2006, 367:133.
173. Schaer C.A., Schoedon G., Imhof A., Kurrer M.O., Schaer D.J. Constitutive endocytosis of CD163 mediates hemoglobin-heme uptake and determines the noninflammatory and protective transcriptional response of macrophages to hemoglobin. Circ. Res. 2006, 99:943.
174. Schaer D.J., Schaer C.A., Schoedon G., Imhof A., Kurrer M.O. Hemophagocytic macrophages constitute a major compartment of heme oxygenase expression in sepsis. Eur. J. Haematol. 2006, 77:432.
175. Schaer C.A., Vallelian F., Imhof A., Schoedon G., Schaer D.J. Heme carrier protein (HCP-1) spatially interacts with the CD163 hemoglobin uptake pathway and is a target of inflammatory macrophage activation. J. Leukoc. Biol. 2008, 83:325.
176. Schaible U.E., Kaufmann S.H. Iron and microbial infection. Nat. Rev. Microbiol. 2004, 2:946.
177. Schmidt P.J., Toran P.T., Giannetti A.M., Bjorkman P.J., Andrews N.C. The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression. Cell Metab. 2008, 7:205.
178. Schrettl M., Bignell E., Kragl C., Joechl C., Rogers T., Arst H.N., Haynes K., Haas H. Siderophore biosynthesis but not reductive iron assimilation is essential for Aspergillus fumigatus virulence. J. Exp. Med. 2004, 200:1213.
179. Schroll A., Eller K., Feistritzer C., Nairz M., Sonnweber T., Moser P.A., Rosenkranz A.R., Theurl I., Weiss G. Lipocalin-2 ameliorates granulocyte functionality. Eur. J. Immunol. 2012, 42:3346.
180. Segers F.M., den Adel B., Bot I., van der Graaf L.M., van der Veer E.P., Gonzalez W., Raynal I., de Winther M., Wodzig W.K., Poelmann R.E., van Berkel T.J., van der Weerd L., Biessen E.A. Scavenger receptor-AI-targeted iron oxide nanoparticles for in vivo MRI detection of atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 2013, 33:1812.
181. Seifert M., Nairz M., Schroll A., Schrettl M., Haas H., Weiss G. Effects of the Aspergillus fumigatus siderophore systems on the regulation of macrophage immune effector pathways and iron homeostasis. Immunobiology 2008, 213:767.
182. Seiser C., Teixeira S., Kuhn L.C. Interleukin-2-dependent transcriptional and post-transcriptional regulation of transferrin receptor mRNA. J. Biol. Chem. 1993, 268:13074.
183. Seixas E., Gozzelino R., Chora A., Ferreira A., Silva G., Larsen R., Rebelo S., Penido C., Smith N.R., Coutinho A., Soares M.P. Heme oxygenase-1 affords protection against noncerebral forms of severe malaria. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:15837.
184. Sengoelge G., Kletzmayr J., Ferrara I., Perschl A., Horl W.H., Sunder-Plassmann G. Impairment of transendothelial leukocyte migration by iron complexes. J. Am. Soc. Nephrol. 2003, 14:2639.
185. Shanmugam N.K., Ellenbogen S., Trebicka E., Wang L., Mukhopadhyay S., Lacy-Hulbert A., Gallini C.A., Garrett W.S., Cherayil B.J. Tumor necrosis factor alpha inhibits expression of the iron regulating hormone hepcidin in murine models of innate colitis. PLoS ONE 2012, 7:e38136.
186. Shayeghi M., Latunde-Dada G.O., Oakhill J.S., Laftah A.H., Takeuchi K., Halliday N., Khan Y., Warley A., McCann F.E., Hider R.C., Frazer D.M., Anderson G.J., Vulpe C.D., Simpson R.J., McKie A.T. Identification of an intestinal heme transporter. Cell 2005, 122:789.
187. Shen C.C., Liang H.J., Wang C.C., Liao M.H., Jan T.R. Iron oxide nanoparticles suppressed T helper 1 cell-mediated immunity in a murine model of delayed-type hypersensitivity. Int. J. Nanomed. 2012, 7:2729.
188. Silva-Gomes S., Appelberg R., Larsen R., Soares M.P., Gomes M.S. Heme catabolism by heme oxygenase-1 confers host resistance to Mycobacterium infection. Infect. Immun. 2013, 81:2536.
189. Sindrilaru A., Peters T., Wieschalka S., Baican C., Baican A., Peter H., Hainzl A., Schatz S., Qi Y., Schlecht A., Weiss J.M., Wlaschek M., Sunderkotter C., Scharffetter-Kochanek K. An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. J. Clin. Invest. 2011, 121:985.
190. Smith K.D. Iron metabolism at the host pathogen interface: lipocalin 2 and the pathogen-associated iroA gene cluster. Int. J. Biochem. Cell Biol. 2007, 39:1776.
191. Soe-Lin S., Sheftel A.D., Wasyluk B., Ponka P. Nramp1 equips macrophages for efficient iron recycling. Exp. Hematol. 2008, 36:929.
192. Soe-Lin S., Apte S.S., Andriopoulos B., Andrews M.C., Schranzhofer M., Kahawita T., Garcia-Santos D., Ponka P. Nramp1 promotes efficient macrophage recycling of iron following erythrophagocytosis in vivo. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:5960.
193. Sonnweber T., Nachbaur D., Schroll A., Nairz M., Seifert M., Demetz E., Haschka D., Mitterstiller A.M., Kleinsasser A., Burtscher M., Trubsbach S., Murphy A.T., Wroblewski V., Witcher D.R., Mleczko-Sanecka K., Vecchi C., Muckenthaler M.U., Pietrangelo A., Theurl I., Weiss G. Hypoxia induced downregulation of hepcidin is mediated by platelet derived growth factor BB. Gut 2014, Published Online First 2014 Mar 5.
194. Sow F.B., Alvarez G.R., Gross R.P., Satoskar A.R., Schlesinger L.S., Zwilling B.S., Lafuse W.P. Role of STAT1, NF-kappaB, and C/EBPbeta in the macrophage transcriptional regulation of hepcidin by mycobacterial infection and IFN-gamma. J. Leukoc. Biol. 2009, 86:1247.
195. Spellberg B., Ibrahim A.S., Chin-Hong P.V., Kontoyiannis D.P., Morris M.I., Perfect J.R., Fredricks D., Brass E.P. The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial. J. Antimicrob. Chemother. 2012, 67:715.
196. Stijlemans B., Vankrunkelsven A., Brys L., Magez S., De Baetselier P. Role of iron homeostasis in trypanosomiasis-associated anemia. Immunobiology 2008, 213:823.
197. Stober C.B., Brode S., White J.K., Popoff J.F., Blackwell J.M. Slc11a1, formerly Nramp1, is expressed in dendritic cells and influences major histocompatibility complex class II expression and antigen-presenting cell function. Infect. Immun. 2007, 75:5059.
198. Stoger J.L., Gijbels M.J., van der Velden S., Manca M., van der Loos C.M., Biessen E.A., Daemen M.J., Lutgens E., de Winther M.P. Distribution of macrophage polarization markers in human atherosclerosis. Atherosclerosis 2012, 225:461.
199. Sullivan J.L. Iron and the sex difference in heart disease risk. Lancet 1981, 1:1293.
200. Sullivan J.L. Re: No association between serum ferritin and asymptomatic carotid atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Am. J. Epidemiol. 1996, 143:1178.
201. Sullivan J.L. Do hemochromatosis mutations protect against iron-mediated atherogenesis?. Circ. Cardiovasc. Genet. 2009, 2:652.
202. Sullivan J.L. Iron in arterial plaque: modifiable risk factor for atherosclerosis. Biochim. Biophys. Acta 2009, 1790:718.
203. Sun J., Brand M., Zenke Y., Tashiro S., Groudine M., Igarashi K. Heme regulates the dynamic exchange of Bach1 and NF-E2-related factors in the Maf transcription factor network. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:1461.
204. Sung K.C., Kang S.M., Cho E.J., Park J.B., Wild S.H., Byrne C.D. Ferritin is independently associated with the presence of coronary artery calcium in 12,033 men. Arterioscler. Thromb. Vasc. Biol. 2012, 32:2525.
205. Swirski F.K., Nahrendorf M. Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science 2013, 339:161.
206. Terashima M., Uchida M., Kosuge H., Tsao P.S., Young M.J., Conolly S.M., Douglas T., McConnell M.V. Human ferritin cages for imaging vascular macrophages. Biomaterials 2011, 32:1430.
207. Theilgaard-Monch K., Jacobsen L.C., Nielsen M.J., Rasmussen T., Udby L., Gharib M., Arkwright P.D., Gombart A.F., Calafat J., Moestrup S.K., Porse B.T., Borregaard N. Haptoglobin is synthesized during granulocyte differentiation, stored in specific granules, and released by neutrophils in response to activation. Blood 2006, 108:353.
208. Theurl I., Fritsche G., Ludwiczek S., Garimorth K., Bellmann-Weiler R., Weiss G. The macrophage: a cellular factory at the interphase between iron and immunity for the control of infections. Biometals 2005, 18:359.
209. Theurl M., Theurl I., Hochegger K., Obrist P., Subramaniam N., van Rooijen N., Schuemann K., Weiss G. Kupffer cells modulate iron homeostasis in mice via regulation of hepcidin expression. J. Mol. Med. (Berl.) 2008, 86:825.
210. Theurl I., Theurl M., Seifert M., Mair S., Nairz M., Rumpold H., Zoller H., Bellmann-Weiler R., Niederegger H., Talasz H., Weiss G. Autocrine formation of hepcidin induces iron retention in human monocytes. Blood 2008, 111:2392.
211. Thorson J.A., Smith K.M., Gomez F., Naumann P.W., Kemp J.D. Role of iron in T cell activation: TH1 clones differ from TH2 clones in their sensitivity to inhibition of DNA synthesis caused by IgG Mabs against the transferrin receptor and the iron chelator deferoxamine. Cell Immunol. 1991, 134:126.
212. Tilg H., Ulmer H., Kaser A., Weiss G. Role of IL-10 for induction of anemia during inflammation. J. Immunol. 2002, 169:2204.
213. Torti F.M., Torti S.V. Regulation of ferritin genes and protein. Blood 2002, 99:3505.
214. Tu C., Ng T.S., Sohi H.K., Palko H.A., House A., Jacobs R.E., Louie A.Y. Receptor-targeted iron oxide nanoparticles for molecular MR imaging of inflamed atherosclerotic plaques. Biomaterials 2011, 32:7209.
215. Van Zandt K.E., Sow F.B., Florence W.C., Zwilling B.S., Satoskar A.R., Schlesinger L.S., Lafuse W.P. The iron export protein ferroportin 1 is differentially expressed in mouse macrophage populations and is present in the mycobacterial-containing phagosome. J. Leukoc. Biol. 2008, 84:689.
216. Vento S., Cainelli F., Cesario F. Infections and thalassaemia. Lancet Infect. Dis. 2006, 6:226.
217. Wagner D., Maser J., Moric I., Boechat N., Vogt S., Gicquel B., Lai B., Reyrat J.M., Bermudez L. Changes of the phagosomal elemental concentrations by Mycobacterium tuberculosis Mramp. Microbiology 2005, 151:323.
218. Wang S.C., Lin K.H., Chern J.P., Lu M.Y., Jou S.T., Lin D.T., Lin K.S. Severe bacterial infection in transfusion-dependent patients with thalassemia major. Clin. Infect. Dis. 2003, 37:984.
219. Wang L., Harrington L., Trebicka E., Shi H.N., Kagan J.C., Hong C.C., Lin H.Y., Babitt J.L., Cherayil B.J. Selective modulation of TLR4-activated inflammatory responses by altered iron homeostasis in mice. J. Clin. Invest. 2009, 119:3322.
220. Wang L., Trebicka E., Fu Y., Ellenbogen S., Hong C.C., Babitt J.L., Lin H.Y., Cherayil B.J. The bone morphogenetic protein-hepcidin axis as a therapeutic target in inflammatory bowel disease. Inflamm. Bowel Dis. 2012, 18:112.
221. Wang W., Deng Z., Hatcher H., Miller L.D., Di X., Tesfay L., Sui G., D'Agostino R.B., Torti F.M., Torti S.V. IRP2 regulates breast tumor growth. Cancer Res. 2014, 74:497.
222. Warszawska J.M., Gawish R., Sharif O., Sigel S., Doninger B., Lakovits K., Mesteri I., Nairz M., Boon L., Spiel A., Fuhrmann V., Strobl B., Muller M., Schenk P., Weiss G., Knapp S. Lipocalin 2 deactivates macrophages and worsens pneumococcal pneumonia outcomes. J. Clin. Invest. 2013, 123:3363.
223. Weiss G. Iron and immunity: a double-edged sword. Eur. J. Clin. Invest. 2002, 32(Suppl. 1):70.
224. Weiss G. Modification of iron regulation by the inflammatory response. Best Pract. Res. Clin. Haematol. 2005, 18:183.
225. Weiss G. Genetic mechanisms and modifying factors in hereditary hemochromatosis. Nat. Rev. Gastroenterol. Hepatol. 2010, 7:50.
226. Weiss G. Intestinal irony: how probiotic bacteria outcompete bad bugs. Cell Host Microbe 2013, 14:3.
227. Weiss G., Goodnough L.T. Anemia of chronic disease. N. Engl. J. Med. 2005, 352:1011.
228. Weiss G., Schett G. Anaemia in inflammatory rheumatic diseases. Nat. Rev. Rheumatol. 2013, 9:205.
229. Weiss G., Fuchs D., Hausen A., Reibnegger G., Werner E.R., Werner-Felmayer G., Wachter H. Iron modulates interferon-gamma effects in the human myelomonocytic cell line THP-1. Exp. Hematol. 1992, 20:605.
230. Weiss G., Goossen B., Doppler W., Fuchs D., Pantopoulos K., Werner-Felmayer G., Wachter H., Hentze M.W. Translational regulation via iron-responsive elements by the nitric oxide/NO-synthase pathway. EMBO J. 1993, 12:3651.
231. Weiss G., Werner-Felmayer G., Werner E.R., Grunewald K., Wachter H., Hentze M.W. Iron regulates nitric oxide synthase activity by controlling nuclear transcription. J. Exp. Med. 1994, 180:969.
232. Weiss G., Wachter H., Fuchs D. Linkage of cell-mediated immunity to iron metabolism. Immunol. Today 1995, 16:495.
233. Weiss G., Bogdan C., Hentze M.W. Pathways for the regulation of macrophage iron metabolism by the anti-inflammatory cytokines IL-4 and IL-13. J. Immunol. 1997, 158:420.
234. Wen S., Liu D.F., Cui Y., Harris S.S., Chen Y.C., Li K.C., Ju S.H., Teng G.J. In vivo MRI detection of carotid atherosclerotic lesions and kidney inflammation in ApoE-deficient mice by using LOX-1 targeted iron nanoparticles. Nanomedicine 2014, 10:639.
235. Wermke M., Schmidt A., Middeke J.M., Sockel K., von Bonin M., Schonefeldt C., Mair S., Plodeck V., Laniado M., Weiss G., Schetelig J., Ehninger G., Theurl I., Bornhauser M., Platzbecker U. MRI-based liver iron content predicts for nonrelapse mortality in MDS and AML patients undergoing allogeneic stem cell transplantation. Clin. Cancer Res. 2012, 18:6460.
236. Werner T., Wagner S.J., Martinez I., Walter J., Chang J.S., Clavel T., Kisling S., Schuemann K., Haller D. Depletion of luminal iron alters the gut microbiota and prevents Crohn's disease-like ileitis. Gut 2011, 60:325.
237. White C., Yuan X., Schmidt P.J., Bresciani E., Samuel T.K., Campagna D., Hall C., Bishop K., Calicchio M.L., Lapierre A., Ward D.M., Liu P., Fleming M.D., Hamza I. HRG1 is essential for heme transport from the phagolysosome of macrophages during erythrophagocytosis. Cell Metab. 2013, 17:261.
238. Wick G., Knoflach M., Xu Q. Autoimmune and inflammatory mechanisms in atherosclerosis. Annu. Rev. Immunol. 2004, 22:361.
239. Yuki K.E., Eva M.M., Richer E., Chung D., Paquet M., Cellier M., Canonne-Hergaux F., Vaulont S., Vidal S.M., Malo D. Suppression of hepcidin expression and iron overload mediate Salmonella susceptibility in ankyrin 1 ENU-induced mutant. PLOS ONE 2013, 8:e55331.
240. Zaharik M.L., Cullen V.L., Fung A.M., Libby S.J., Kujat Choy S.L., Coburn B., Kehres D.G., Maguire M.E., Fang F.C., Finlay B.B. The Salmonella enterica serovar typhimurium divalent cation transport systems MntH and SitABCD are essential for virulence in an Nramp1G169 murine typhoid model. Infect. Immun. 2004, 72:5522.
241. Zhang Z., Zhang F., An P., Guo X., Shen Y., Tao Y., Wu Q., Zhang Y., Yu Y., Ning B., Nie G., Knutson M.D., Anderson G.J., Wang F. Ferroportin1 deficiency in mouse macrophages impairs iron homeostasis and inflammatory responses. Blood 2011, 118:1912.
242. Zhong W., Lafuse W.P., Zwilling B.S. Infection with Mycobacterium avium differentially regulates the expression of iron transport protein mRNA in murine peritoneal macrophages. Infect. Immun. 2001, 69:6618.
243. Zughaier S.M., Kandler J.L., Shafer W.M. Neisseria gonorrhoeae modulates iron-limiting innate immune defenses in macrophages. PLOS ONE 2014, 9:e87688.